【万泰生物:预计2024年净利润同比减少93.11%到90.38%】万泰生物公告,预计2024年年度实现归属于母公司所有者的净利润为8600万元到1.2亿元,与上年同期12.48亿元相比,将减少11.62亿元到11.28亿元,同比减少93.11%到90.38%。预计2024年年度实现归属于母公司所有者的扣除非经常性损益的净利润为-2.2亿元到-1.55亿元,与上年同期10.78亿元相比,将减少12.98亿元到12.33亿元,同比减少120.40%到114.38%。

金融界
15 Jan
万泰生物公告,预计2024年年度实现归属于母公司所有者的净利润为8600万元到1.2亿元,与上年同期12.48亿元相比,将减少11.62亿元到11.28亿元,同比减少93.11%到90.38%。预计2024年年度实现归属于母公司所有者的扣除非经常性损益的净利润为-2.2亿元到-1.55亿元,与上年同期10.78亿元相比,将减少12.98亿元到12.33亿元,同比减少120.40%到114.38%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10